Monroe Bank & Trust’s Gilead Sciences GILD Stock Holding History

Monroe Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-69	Closed	-$5K	–	285
2016 Q4	$5K	Buy	+69	New	+$5.13K	﹤0.01%	283
2016 Q2	–	Sell	-369	Closed	-$34K	–	194
2016 Q1	$34K	Buy	369 +69	+23%	+$6.22K	0.01%	192
2015 Q4	$30K	Hold	300	–	–	0.01%	198
2015 Q3	$29K	Hold	300	–	–	0.01%	199
2015 Q2	$35K	Hold	300	–	–	0.01%	190
2015 Q1	$29K	Hold	300	–	–	0.01%	198
2014 Q4	$28K	Buy	+300	New	+$31K	0.01%	199
2014 Q3	–	Sell	-300	Closed	-$25K	–	188
2014 Q2	$25K	Hold	300	–	–	0.01%	227
2014 Q1	$21K	Hold	300	–	–	0.01%	242
2013 Q4	$23K	Hold	300	–	–	0.01%	228
2013 Q3	$19K	Sell	300 -150	-33%	-$8.96K	0.01%	223
2013 Q2	$23K	Buy	+450	New	+$23.5K	0.01%	213

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Monroe Bank & Trust's GILD Position: Q1 2017 in Review

Monroe Bank & Trust sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 69 shares — an estimated $5K sold.

Monroe Bank & Trust first reported a position in GILD in Q2 2013 and held it in 12 quarters. The position peaked at $35K in Q2 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

Monroe Bank & Trust reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
Monroe Bank & Trust sold 69 Gilead Sciences shares in Q1 2017, an estimated $5K.
Monroe Bank & Trust first reported a position in Gilead Sciences in Q2 2013 and held it in 12 quarters.
Monroe Bank & Trust's Gilead Sciences position peaked at $35K in Q2 2015.
1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Monroe Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.